TVA Medical Lands $15,000,000 Series C Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f34d3e51-f4ed-40c1-9bf8-183b521f5dc8 - Date
10/6/2015 - Company Name
TVA Medical - Mailing Address
7000 Bee Cave Rd. Austin, TX 78746 USA - Company Description
TVA Medical, Inc. (TVA) is a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD). - Website
http://www.tvamedical.com - Transaction Type
Venture Equity - Transaction Amount
$15,000,000 - Transaction Round
Series C - Proceeds Purposes
The investment round will support continuation of clinical activities and acceleration of market development for the everlinQ endoAVF System, a catheter-based technology designed to create hemodialysis access for chronic kidney disease patients in a minimally invasive procedure. Funds will support the ongoing Novel Endovascular Access Trial (NEAT) clinical study (12-month follow up to complete in 2016) and additional global clinical research, as well as device reimbursement and market access initiatives. - M&A Terms
- Venture Investor
Baxter Ventures - Venture Investor
Boston Scientific Corporation - Venture Investor
Sante Ventures - Venture Investor
S3 Ventures - Venture Investor
TriStar Technology Fund - Venture Investor
Undisclosed
